PRED MILD Drug Patent Profile
✉ Email this page to a colleague
When do Pred Mild patents expire, and when can generic versions of Pred Mild launch?
Pred Mild is a drug marketed by Abbvie and is included in one NDA.
The generic ingredient in PRED MILD is prednisolone acetate. There are eighty-eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the prednisolone acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PRED MILD?
- What are the global sales for PRED MILD?
- What is Average Wholesale Price for PRED MILD?
Summary for PRED MILD
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 74 |
Patent Applications: | 3,812 |
Drug Prices: | Drug price information for PRED MILD |
What excipients (inactive ingredients) are in PRED MILD? | PRED MILD excipients list |
DailyMed Link: | PRED MILD at DailyMed |
![PRED MILD drug patent expirations Drug patent expirations by year for PRED MILD](/p/graph/s/t/PRED_MILD-patent-expirations.png)
![Drug Prices for PRED MILD](/p/graph/drug-price/PRED+MILD.png)
![Drug Sales Revenue Trends for PRED MILD](/p/graph/drug-sales-revenues/PRED+MILD.png)
Pharmacology for PRED MILD
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for PRED MILD
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | PRED MILD | prednisolone acetate | SUSPENSION/DROPS;OPHTHALMIC | 017100-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |